Cite
Farnesoid X Receptor (FXR) Activation and FXR Genetic Variation in Inflammatory Bowel Disease.
MLA
Nijmeijer, Rian M., et al. “Farnesoid X Receptor (FXR) Activation and FXR Genetic Variation in Inflammatory Bowel Disease.” PLoS ONE, vol. 6, no. 8, Aug. 2011, pp. 1–6. EBSCOhost, https://doi.org/10.1371/journal.pone.0023745.
APA
Nijmeijer, R. M., Gadaleta, R. M., van Mil, S. W. C., Bodegraven, A. A. van, Crusius, J. B. A., Dijkstra, G., Hommes, D. W., Jong, D. J. de, Stokkers, P. C. F., Verspaget, H. W., Weersma, R. K., Woude, C. J. van der, Stapelbroek, J. M., Schipper, M. E. I., Wijmenga, C., Erpecum, K. J. van, & Oldenburg, B. (2011). Farnesoid X Receptor (FXR) Activation and FXR Genetic Variation in Inflammatory Bowel Disease. PLoS ONE, 6(8), 1–6. https://doi.org/10.1371/journal.pone.0023745
Chicago
Nijmeijer, Rian M., Raffaella M. Gadaleta, Saskia W. C. van Mil, Adriaan A. van Bodegraven, J. Bart A. Crusius, Gerard Dijkstra, Daan W. Hommes, et al. 2011. “Farnesoid X Receptor (FXR) Activation and FXR Genetic Variation in Inflammatory Bowel Disease.” PLoS ONE 6 (8): 1–6. doi:10.1371/journal.pone.0023745.